University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 7H-18-2


Accuracy Study: A Phase 2, Open-Label, Single-Arm, Multi-Center Study of AL101 in Patients with Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Anti-Angiogenesis
Randomized: Not Asked
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Bing Xia, M.D.
Other Trial Staff:  Victoria Amran, D.M., Gina Tse, Coordinator, Eduardo Mejia, D.M., Laurie De Oliveira, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.